Publication: Mapping the peptide interaction fingerprint of the Behçet's disease-associated HLA-B(∗)51
| dc.contributor.coauthor | Yilmaz, S. Z. | |
| dc.contributor.coauthor | Basturk, D. | |
| dc.contributor.coauthor | Gul, A. | |
| dc.contributor.coauthor | Gur, M. | |
| dc.contributor.department | Department of Chemical and Biological Engineering | |
| dc.contributor.kuauthor | Erman, Burak | |
| dc.contributor.schoolcollegeinstitute | College of Engineering | |
| dc.date.accessioned | 2026-07-07T08:49:59Z | |
| dc.date.issued | 2026 | |
| dc.description.abstract | The strongest genetic risk factor for Behçet’s disease, a relapsing inflammatory disorder marked by recurrent mucocutaneous ulcers and uveitis, is HLA-B∗51:01, a class I major histocompatibility complex (MHC class I) allele that presents intracellular peptides to CD8+ T cells. The molecular mechanisms linking the peptide preferences of this allele to dysregulated immunity remain unclear, limiting efforts to design peptide-based modulators of antigen presentation. Here, we define HLA-B∗51:01’s peptide selection rules by mapping the “interaction fingerprint” of 36 self-peptides using an extensive set of all-atom molecular dynamics simulations. These uncovered a conserved hydrophobic-polar blueprint tuned by peptide length. In silico pulling experiments performed at high-speed atomic force microscopy-like loading rates suggest a three-tier hierarchy of mechanical resilience: 9-mers resist the highest forces, 8-mers exhibit intermediate resistance, and 10-/11-mers rupture most easily. Our comprehensive analysis provides an atomistic framework for understanding the molecular mechanisms underlying the HLA-B∗51:01 pathobiology and offers quantitative parameters to guide the design of therapeutic peptides or small molecules to modulate antigen presentation in Behçet’s disease. | |
| dc.description.harvestedfrom | Manual | |
| dc.description.indexedby | PubMed | |
| dc.description.publisherscope | International | |
| dc.description.readpublish | N/A | |
| dc.description.sponsoredbyTubitakEu | TÜBİTAK | |
| dc.description.version | Published Version | |
| dc.identifier.WoSQuartile | N/A | |
| dc.identifier.doi | 10.1016/j.bpj.2026.04.028 | |
| dc.identifier.eissn | 1542-0086 | |
| dc.identifier.embargo | N/A | |
| dc.identifier.grantno | 119Z553 | |
| dc.identifier.issn | 0006-3495 | |
| dc.identifier.pubmed | 42036944 | |
| dc.identifier.uri | http://doi.org/10.1016/j.bpj.2026.04.028 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14288/33300 | |
| dc.keywords | Peptide | |
| dc.keywords | Major histocompatibility complex | |
| dc.keywords | Antigen presentation | |
| dc.keywords | Allele | |
| dc.keywords | Biotinylation | |
| dc.keywords | Epitope | |
| dc.keywords | Antigen | |
| dc.keywords | Limiting | |
| dc.language | eng | |
| dc.publisher | Cell Press | |
| dc.relation.affiliation | Koç University | |
| dc.relation.collection | Koç University Institutional Repository | |
| dc.relation.ispartof | Biophysical Journal | |
| dc.relation.openaccess | N/A | |
| dc.rights | N/A | |
| dc.rights.uri | N/A | |
| dc.subject | Medicine | |
| dc.title | Mapping the peptide interaction fingerprint of the Behçet's disease-associated HLA-B(∗)51 | |
| dc.type | Journal Article | |
| dspace.entity.type | Publication | |
| relation.isOrgUnitOfPublication | c747a256-6e0c-4969-b1bf-3b9f2f674289 | |
| relation.isOrgUnitOfPublication.latestForDiscovery | c747a256-6e0c-4969-b1bf-3b9f2f674289 | |
| relation.isParentOrgUnitOfPublication | 8e756b23-2d4a-4ce8-b1b3-62c794a8c164 | |
| relation.isParentOrgUnitOfPublication.latestForDiscovery | 8e756b23-2d4a-4ce8-b1b3-62c794a8c164 |
